Unknown

Dataset Information

0

Insights into the Cross Talk between Effector and Allosteric Lobes of KRAS from Methyl Conformational Dynamics.


ABSTRACT: KRAS is the most frequently mutated RAS protein in cancer patients, and it is estimated that about 20% of the cancer patients in the United States carried mutant RAS proteins. To accelerate therapeutic development, structures and dynamics of RAS proteins had been extensively studied by various biophysical techniques for decades. Although 31P NMR studies revealed population equilibrium of the two major states in the active GMPPNP-bound form, more complex conformational dynamics in RAS proteins and oncogenic mutants subtly modulate the interactions with their downstream effectors. We established a set of customized NMR relaxation dispersion techniques to efficiently and systematically examine the ms-μs conformational dynamics of RAS proteins. This method allowed us to observe varying synchronized motions that connect the effector and allosteric lobes in KRAS. We demonstrated the role of conformational dynamics of KRAS in controlling its interaction with the Ras-binding domain of the downstream effector RAF1, the first kinase in the MAPK pathway. This allows one to explain, as well as to predict, the altered binding affinities of various KRAS mutants, which was neither previously reported nor apparent from the structural perspective.

SUBMITTER: Chao FA 

PROVIDER: S-EPMC10430694 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Insights into the Cross Talk between Effector and Allosteric Lobes of KRAS from Methyl Conformational Dynamics.

Chao Fa-An FA   Dharmaiah Srisathiyanarayanan S   Taylor Troy T   Messing Simon S   Gillette William W   Esposito Dominic D   Nissley Dwight V DV   McCormick Frank F   Byrd R Andrew RA   Simanshu Dhirendra K DK   Cornilescu Gabriel G  

Journal of the American Chemical Society 20220225 9


KRAS is the most frequently mutated RAS protein in cancer patients, and it is estimated that about 20% of the cancer patients in the United States carried mutant RAS proteins. To accelerate therapeutic development, structures and dynamics of RAS proteins had been extensively studied by various biophysical techniques for decades. Although <sup>31</sup>P NMR studies revealed population equilibrium of the two major states in the active GMPPNP-bound form, more complex conformational dynamics in RAS  ...[more]

Similar Datasets

| S-EPMC11755325 | biostudies-literature
| S-EPMC2895362 | biostudies-other
| S-EPMC4303274 | biostudies-literature
| S-EPMC6396121 | biostudies-literature
| S-EPMC5326564 | biostudies-literature
| S-EPMC5379107 | biostudies-literature
| S-EPMC5735167 | biostudies-literature
| S-EPMC2785677 | biostudies-literature
| S-EPMC2898380 | biostudies-literature
| S-EPMC6428901 | biostudies-literature